XinThera has a total of 159 patents globally, out of which 24 have been granted. Of these 159 patents, more than 91% patents are active. United States of America is where XinThera has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of XinThera.
XinThera founded in 2021, XinThera is a drug discovery company focused on developing precision small molecule therapies for cancer and immunologic diseases. Leveraging advanced computational chemistry, the company targets well-validated but previously intractable pathways in oncology and immunology. XinThera aims to deliver innovative treatments that address critical unmet medical needs.
Do read about some of the most popular patents of XinThera which have been covered by us in this article and also you can find XinThera patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over XinThera patent portfolio.
How many patents does XinThera have?
XinThera has a total of 159 patents globally. These patents belong to 20 unique patent families. Out of 159 patents, 145 patents are active.
How Many Patents did XinThera File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | XinThera Applications Filed | XinThera Patents Granted |
| 2025 | 6 | 13 |
| 2024 | 36 | 7 |
| 2023 | 65 | 4 |
| 2022 | 52 | – |
How many XinThera patents are Alive/Dead?
Worldwide Patents
How Many Patents did XinThera File in Different Countries?
Countries in which XinThera Filed Patents
| Country | Patents |
| United States of America | 19 |
| Hong Kong (S.A.R.) | 12 |
| Australia | 12 |
| China | 10 |
| Europe (EPO) | 9 |
| Taiwan | 9 |
| India | 8 |
| New Zealand | 6 |
| Israel | 6 |
| Singapore | 6 |
| Canada | 6 |
| South Africa | 5 |
| Brazil | 5 |
| Mexico | 4 |
| Malaysia | 4 |
| Dominican Republic | 3 |
| Indonesia | 3 |
| Costa Rica | 3 |
| Philippines | 3 |
| Chile | 3 |
| Colombia | 3 |
| Africa | 3 |
| Viet Nam | 2 |
| Peru | 2 |
| Denmark | 1 |
Where are Research Centres of XinThera Patents Located?
10 Best XinThera Patents
WO2022225934A1 is the most popular patent in the XinThera portfolio. It has received 49 citations so far from companies like Minghui Pharmaceutical (Hangzhou) Co, Slap Pharmaceuticals & Enliven Inc.
Below is the list of 10 most cited patents of XinThera:
| Publication Number | Citation Count |
| WO2022225934A1 | 49 |
| WO2022212489A1 | 19 |
| WO2023056039A1 | 13 |
| WO2023283338A1 | 11 |
| WO2023146957A1 | 10 |
| WO2023146960A1 | 9 |
| WO2023212219A1 | 5 |
| US11591331B2 | 4 |
| US20230159525A1 | 4 |
| US20230128041A1 | 4 |
What Percentage of XinThera US Patent Applications were Granted?
XinThera (Excluding its subsidiaries) has filed 19 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 9 have been granted leading to a grant rate of 75.0%.
Below are the key stats of XinThera patent prosecution at the USPTO.
Which Law Firms are managing US Patents for XinThera?
| Law Firm | Total Applications | Success Rate |
| Sheppard Mullin Richter & Hampton Llp | 19 | 75.00% |
What are XinThera key innovation segments?
What Technologies are Covered by XinThera?
The chart below distributes patents filed by XinThera in different countries on the basis of the technology protected in patents. It also represents the markets where XinThera thinks it’s important to protect particular technological inventions.
R&D Focus: How has XinThera search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by XinThera?
